BRAF and colorectal carcinoma: When used to test for the v-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E mutation in colorectal carcinomas, the current model demonstrated 100% diagnostic sensitivity, 87.5% diagnostic specificity and 93.8% diagnostic accuracy.